• SGs are associated with AD through bidirectional interactions with tau pathology, RNA dysregulation, and proteostatic collapse. • SG modulation is a potential therapeutic strategy for AD. • Autophagy enhancers (mTOR inhibitors, myricetin), show promise in reducing tau pathology.
Building similarity graph...
Analyzing shared references across papers
Kashtiban et al. (Mon,) studied this question.
Loading...
Brain Research Bulletin
Shahid Beheshti University of Medical Sciences
Tabriz University of Medical Sciences
Islamic Azad University of Ahar
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.